3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one

C25H17FN8O2 — CID 134461314

IUPAC3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
SMILESO=C1Nc2ccccc2C(c2ccccc2)=NC1Nc1nnc(-c2ccc(-n3cncn3)c(F)c2)o1
InChIInChI=1S/C25H17FN8O2/c26-18-12-16(10-11-20(18)34-14-27-13-28-34)24-32-33-25(36-24)31-22-23(35)29-19-9-5-4-8-17(19)21(30-22)15-6-2-1-3-7-15/h1-14,22H,(H,29,35)(H,31,33)
InChIKeyXYNWKHMXJXOPPE-UHFFFAOYSA-N
MW480.46 g/mol
LogP3.68
Rot. Bonds5

About 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one

3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one (PubChem CID 134461314) has the molecular formula C25H17FN8O2 and a molecular weight of 480.46 g/mol. Its IUPAC name is 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one.

Molecular Properties

Compound Name3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
PubChem CID134461314
Molecular FormulaC25H17FN8O2
Molecular Weight480.46 g/mol
Exact Mass480.15
IUPAC Name3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
SMILESO=C1Nc2ccccc2C(c2ccccc2)=NC1Nc1nnc(-c2ccc(-n3cncn3)c(F)c2)o1
InChIInChI=1S/C25H17FN8O2/c26-18-12-16(10-11-20(18)34-14-27-13-28-34)24-32-33-25(36-24)31-22-23(35)29-19-9-5-4-8-17(19)21(30-22)15-6-2-1-3-7-15/h1-14,22H,(H,29,35)(H,31,33)
InChIKeyXYNWKHMXJXOPPE-UHFFFAOYSA-N
XLogP3.68
TPSA123.12 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds5
Heavy Atoms36
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500480.46
LogP ≤ 53.68
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one?
The IUPAC name of 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one (CID 134461314) is 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one.
What is the SMILES notation for 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one?
The canonical SMILES for 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one is O=C1Nc2ccccc2C(c2ccccc2)=NC1Nc1nnc(-c2ccc(-n3cncn3)c(F)c2)o1.
What is the InChIKey of 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one?
The InChIKey is XYNWKHMXJXOPPE-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H17FN8O2/c26-18-12-16(10-11-20(18)34-14-27-13-28-34)24-32-33-25(36-24)31-22-23(35)29-19-9-5-4-8-17(19)21(30-22)15-6-2-1-3-7-15/h1-14,22H,(H,29,35)(H,31,33).
What are the key properties of 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one?
3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one has a molecular weight of 480.46 g/mol, XLogP of 3.68, 5 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[5-[3-fluoro-4-(1,2,4-triazol-1-yl)phenyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one is sourced from PubChem (CID 134461314), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).